BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 21, 2026
See today's BioWorld
Home
» Other news to note for April 6, 2022
To read the full article
sign up for free
or
sign in
.
Other news to note for April 6, 2022
April 6, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3CL, Abbvie, Addex, Agenus, Aligos, Alloy, Alvotech, Atara, Atreca, AVM, Awakn, Axantia, Betterlife, Biotech Acquisition, Cellpoint, Dragon Overseas, Golden Mountain, HDT, Intas, Isto, Stada, Neurona, Novartis, Neuro-Bio, Novo Nordisk, Oncotelic, Oragenics, Pregene, Regeneron, SQZ, Synaptogenix, Swanbio, Tegmine, Theracell, Todos, Treadwell, Vigeneron, Zymeworks.
BioWorld
Briefs
Other news to note
Coronavirus